                         SEQUENCE LISTING

<110>  INVECTORS S.r.l.
 
<120>  Supramolecular aggregates containing amphiphilic monomers, 
       chelating agents and peptides for use for drug delivery
       and as contrast agents

<130>  PC1163PR

<160>  12    

<170>  PatentIn version 3.3

<210>  1
<211>  14
<212>  PRT
<213>  Bombina bombina

<400>  1

Gln Gln Arg Leu Gly Asn Gln Trp Ala Val Gly His Leu Met 
1               5                   10                  


<210>  2
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Analogs of C-terminal bombesin fragments


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is selected from D-Phe, D-Tyr, D-Trp or is absent

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is selected from NMeGly, Gly or beta-Ala

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is selected from Leu, Cha, Sta, Met or Nle

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is selected from Met, Leu or Nle

<400>  2

Xaa Gln Trp Ala Val Xaa His Xaa Xaa 
1               5                   


<210>  3
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Preferred peptide sequence # 1


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is Nle

<400>  3

Gln Trp Ala Val Gly His Leu Xaa 
1               5               


<210>  4
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Preferred peptide sequence # 2


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Cha

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is Nle

<400>  4

Gln Trp Ala Val Gly His Xaa Xaa 
1               5               


<210>  5
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Preferred peptide sequence # 3


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Cha

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is Nle

<400>  5

Gln Trp Ala Val Gly His Xaa Xaa Glu 
1               5                   


<210>  6
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Preferred peptide sequence # 4


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Sta

<400>  6

Gln Trp Ala Val Gly His Xaa Leu 
1               5               


<210>  7
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Preferred peptide sequence # 5


<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is NMeGly

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Sta

<400>  7

Gln Trp Ala Val Xaa His Xaa Leu 
1               5               


<210>  8
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Preferred peptide sequence # 6


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is D-Phe

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is Sta

<400>  8

Xaa Gln Trp Ala Val Gly His Xaa Leu 
1               5                   


<210>  9
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Preferred peptide sequence # 7


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is D-Phe

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is Cha

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is Nle

<400>  9

Xaa Gln Trp Ala Val Gly His Xaa Xaa 
1               5                   


<210>  10
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Preferred peptide sequence # 8


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is D-Phe

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is NMeGly

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is Sta

<400>  10

Xaa Gln Trp Ala Val Xaa His Xaa Leu 
1               5                   


<210>  11
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Preferred peptide sequence # 9

<400>  11

Gln Trp Ala Val Gly His Leu Met 
1               5               


<210>  12
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Preferred peptide sequence # 10


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is D-Phe

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is NMeGly

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is Nle

<400>  12

Xaa Gln Trp Ala Val Xaa His Leu Xaa 
1               5                   


